Company Filing History:
Years Active: 2019-2025
Title: Innovator Anuar Imanbayev: Advancing Diabetes Management through Technology
Introduction
Anuar Imanbayev is an accomplished inventor based in Seattle, WA, specializing in medical technologies that enhance diabetes management. With three patents to his name, Imanbayev is at the forefront of developing innovative solutions that leverage data and machine learning to improve patient outcomes.
Latest Patents
One of Imanbayev's most notable inventions is the "Insulin titration algorithm based on patient profile." This patent describes a device, system, and method that predict the risk of hypoglycemia and adjust insulin dosage for patients using pen-based multi-daily injections. The invention employs a first algorithm that computes insulin dose sizes based on timestamped blood glucose measurements and injected insulin amounts. The risk prediction module utilizes machine learning algorithms to predict hypoglycemia risk and adjust insulin doses accordingly.
Another significant patent is the "System for providing an up-to-date and long-acting or ultra-long-acting insulin dose guidance recommendation to treat diabetes mellitus." This invention outlines a novel administration regime that benefits patients requiring insulin therapy. It includes a detailed process of collecting data sets and structures of the subject to provide tailored insulin dose guidance.
Career Highlights
Anuar Imanbayev is currently associated with Novo Nordisk A/S, a leading company in diabetes care and management. His work there focuses on developing cutting-edge solutions that help improve insulin delivery and patient care for those living with diabetes.
Collaborations
Throughout his career, Imanbayev has collaborated with esteemed colleagues such as Thomas Dedenroth Miller and Alan John Michelich. These partnerships have fueled innovation and brought valuable insights into the development of diabetes treatment technologies.
Conclusion
Anuar Imanbayev exemplifies the spirit of innovation in the medical technology sector. With his expertise and dedication, he continues to make significant contributions to diabetes management, ensuring better health outcomes for patients worldwide. His patented inventions not only showcase his technical prowess but also reflect a commitment to improving the quality of life for those with diabetes.